EGFR and non-small cell lung carcinoma: We also expanded our analysis of the cytotoxic potential of mandelalide A alone and as a combinatorial treatment in representative NSCLC cells that have a tumor suppressor liver kinase B1 (LKB1) deletion and that harbor clinically-relevant mutations in endothelial growth factor receptor (EGFR).